KALA BIO Inc

KALA BIO Inc

Kala Pharmaceuticals develops treatments for the prevention and diagnosis of diseases of the eye

Stock Performance Snapshot

Buy

Analyst Rating

Analysts suggest purchasing KALA BIO Inc's stock with a target price of $11.75, indicating strong growth potential.

Above Average

Financial Health

KALA BIO Inc is generating strong cash flow per share, indicating healthy financial performance.

Source: Analyst sentiment is provided by Refinitiv Ltd, a global leader in financial market data with over 40k business clients. Refinitiv Ltd is an independent third party to Nemo. This is not advice.

Baskets Featuring KALA

Education in the Spotlight

Education in the Spotlight

This carefully selected group of stocks features companies that could benefit from McGraw Hill's upcoming $4.2 billion IPO. Our professional analysts have identified these educational publishers, digital platforms, and service providers as potential beneficiaries of renewed investor interest in the education sector.

Published: July 15, 2025

Explore Basket

Why You’ll Want to Watch This Stock

📈

Clinical Milestones Ahead

Progress in trials or approvals can be a key value driver, though outcomes are uncertain and timing can shift.

Financing Sensitivity

Small biotech firms often need fresh capital; fundraising can dilute existing holders and influence the share price.

🌍

Research Due Diligence

Check filings, cash runway and management commentary to understand catalysts and the company’s strategic direction.

Why invest with Nemo?

Nemo Logo Fade
🆓

Zero Commission

Trade stocks, ETFs, and more with zero commission. Keep more of your returns.

🔒

Trusted & Regulated

Part of Exinity Group 2015, serving over a million customers globally.

💰

6% Interest on Cash

Earn 6% AER on uninvested cash with daily interest payments.

Discover More Opportunities

LLY

Eli Lilly and Company

Eli Lilly & Co is a global pharmaceutical company that develops, manufactures and markets human prescription drugs.

JNJ

Johnson & Johnson

Johnson & Johnson is a multinational conglomerate pharmaceutical, medical devices, and consumer packaged goods company.

ABBV

AbbVie Inc.

Abbvie is a research-based biopharmaceutical company that develops and markets advanced therapies to address complex medical conditions.

Frequently asked questions